Status:
COMPLETED
Pharmacokinetic Study of Testosterone Enanthate
Lead Sponsor:
Antares Pharma Inc.
Conditions:
Hypogonadism
Eligibility:
MALE
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Relative Bioavailability and Safety comparison of 3 formulations of Testosterone Enanthate.
Detailed Description
Standard Pharmacokinetic (PK) analyses of data for serum testosterone were done. Cmax, Area Under Curve (AUC), and Cavg were used for the comparison of relative bioavailability of the treatments and r...
Eligibility Criteria
Inclusion
- Adult males aged 18 to 75 with a documented diagnosis of hypogonadism
Exclusion
- Normal testosterone levels
- Subjects with any clinically significant medical condition which, in the opinion of the Investigator, would make the subject an unsuitable candidate for enrollment in the study
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01887418
Start Date
September 1 2013
End Date
January 1 2014
Last Update
January 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mens Health Boston
Brookline, Massachusetts, United States, 02445